What is polymorphic pleocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polymorphic Pleocytosis: Definition and Clinical Significance

Polymorphic (or polymorphonuclear) pleocytosis refers to an abnormal increase in white blood cells in the cerebrospinal fluid (CSF) where neutrophils (polymorphonuclear leukocytes) are the predominant cell type, typically exceeding 5 cells per microliter. 1, 2

Key Characteristics

  • Cell composition: Predominantly neutrophils/polymorphonuclear cells (PMNs) rather than lymphocytes 1
  • Cell count range: Can vary from mild elevations (tens of cells) to several hundred or even thousands of cells per microliter, depending on the underlying cause 1, 2
  • Associated findings: Often accompanied by elevated protein (100-200 mg/dL) and variable glucose levels 1

Clinical Significance and Differential Diagnosis

Infectious Causes

Bacterial meningitis is the most critical diagnosis to consider with polymorphic pleocytosis, typically presenting with:

  • Very low CSF glucose (<20-30 mg/dL) 1
  • Markedly elevated protein 1
  • Neutrophilic predominance with high cell counts 1

Tickborne rickettsial diseases (Rocky Mountain Spotted Fever, ehrlichiosis, E. ewingii infection) characteristically produce neutrophilic pleocytosis 1:

  • E. ewingii infection specifically shows neutrophilic pleocytosis 1
  • RMSF can show either polymorphonuclear or lymphocytic predominance 1

Partially treated bacterial meningitis may present with polymorphic pleocytosis but modified CSF parameters 1

Non-Infectious Causes

Post-seizure pleocytosis can produce polymorphic pleocytosis 3, 4:

  • 57% of seizure-related pleocytosis shows PMN predominance 3
  • 86% of alcohol withdrawal seizures demonstrate PMN predominance 3
  • Mean white cell count of 72/mm³ (range 3-464) 3
  • Typically transient and resolves within days 3

CMV polyradiculomyelopathy presents with neutrophilic pleocytosis (usually 100-200 neutrophils/mL) accompanied by hypoglycorrhachia and elevated protein 1

Tuberculous meningitis during treatment can paradoxically develop sudden polymorphonuclear pleocytosis 4-108 days after starting chemotherapy, which resolves within a week 5

Diagnostic Approach

Critical Distinguishing Features

CSF glucose is the key discriminator 1:

  • CSF glucose <20-30 mg/dL or CSF:plasma glucose ratio <0.5 strongly suggests bacterial meningitis 1
  • Normal glucose with polymorphic pleocytosis suggests non-infectious causes (seizures, post-treatment inflammation) 3, 5

CSF lactate measurement provides rapid differentiation 1:

  • CSF lactate <2 mmol/L effectively rules out bacterial disease 1
  • Elevated lactate supports bacterial infection 1

Gram stain findings 1:

  • Gram-negative diplococci indicate meningococcal meningitis 1
  • Positive Gram stain with polymorphic pleocytosis mandates immediate antibiotic therapy 1

Clinical Context Matters

Timing and clinical presentation guide interpretation 1, 3:

  • Acute onset with fever, altered mental status, and meningismus suggests bacterial meningitis requiring immediate empiric antibiotics 1
  • Recent seizure activity with rapid clinical recovery suggests post-ictal pleocytosis 3, 4
  • Patients on tuberculosis treatment developing new pleocytosis may have paradoxical inflammatory response 5

Critical Management Pitfall

When polymorphic pleocytosis is present with fever and rash, and bacterial meningitis cannot be definitively excluded, empiric treatment for both tickborne rickettsial disease AND meningococcal infection is necessary, as laboratory testing cannot reliably distinguish between these conditions. 1 This dual coverage approach prioritizes patient survival over diagnostic certainty in critically ill patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lymphocytic Pleocytosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cerebrospinal fluid pleocytosis after seizures.

Southern medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.